Zimmer Biomet Holdings, Inc.
ZBH
Updated: 24/09/2026, 04:37:16
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
No summaries found.
The original document can be viewed now. Detailed facts and exposure relationships will appear after the separate extraction job completes.
- Share price
- $90.88
- Market cap
- $17.58B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Ivan Tornos
- Employees
- 17,000
- IPO date
- 25/07/2001
- Beta
- 0.471
- Last dividend
- $0.00
- Day range
- $89.87 – $93.25
- 52-week range
- $79.12 – $106.88
- 1-day performance
- -3.30%
- 1-year performance
- 14.86%
- Current drawdown (1Y)
- -14.97%
- CIK
- 0001136869
- CUSIP
- 98956P102
- ISIN
- US98956P1021
- Created
- 07/12/2025, 15:13:22
- Last update
- 24/09/2026, 04:37:16
Track Zimmer Biomet Holdings, Inc. with an AI analyst
See which prediction-market events move ZBH, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 08/06/2026, 19:08:30
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026
PRNewsWire • STOCK • 22/05/2026, 18:30:00
Zimmer Biomet Holdings, Inc. (ZBH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 13/05/2026, 17:31:06
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Zacks Investment Research • STOCK • 01/05/2026, 12:40:38
Zimmer Biomet Holdings, Inc. (ZBH) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 28/04/2026, 16:11:44
Zimmer Biomet (ZBH) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research • STOCK • 28/04/2026, 10:41:09
Zimmer Biomet Announces First Quarter 2026 Financial Results
PRNewsWire • STOCK • 28/04/2026, 08:30:00
Here's How Zimmer Biomet Is Placed Ahead of Q1 Earnings
Zacks Investment Research • STOCK • 20/04/2026, 11:35:47
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
PRNewsWire • STOCK • 09/04/2026, 09:30:00
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
PRNewsWire • STOCK • 07/04/2026, 09:30:00
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now?
Zacks Investment Research • STOCK • 25/03/2026, 10:25:25
Zimmer Biomet Downgraded by BTIG on Limited Near-Term Upside
Market Data • Market Data • 23/03/2026, 16:43:57